|
1
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent. J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis - correlation in invasive
breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Macchiarini P, Fontanini G, Hardin MJ,
Squartini F and Angeletti CA: Relation of neovascularisation to
metastasis of non-small-cell lung cancer. Lancet. 340:145–146.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
SmithMcCune KK and Weidner N:
Demonstration and characterization of the angiogenic properties of
cervical dysplasia. Cancer Res. 54:800–804. 1994.PubMed/NCBI
|
|
5
|
Ferrara N and Bunting S: Vascular
endothelial growth factor, a specific regulator of angiogenesis.
Curr Opin Nephrol Hypertens. 5:35–44. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jones N, Iljin K, Dumont DJ and Alitalo K:
Tie receptors: new modulators of angiogenic and lymphangiogenic
responses. Nat Rev Mol Cell Biol. 2:257–267. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koch AE, Polverini PJ, Kunkel SL, Harlow
LA, DiPietro LA, Elner VM, Elner SG and Strieter RM: Interleukin-8
as a macrophage-derived mediator of angiogenesis. Science.
258:1798–1801. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu N, Gao Y, Ling Y, Chen Y, Yang Y, Gu
HY, Qi Q, Liu W, Wang XT, You QD and Guo QL: Wogonin suppresses
tumor growth in vivo and VEGF-induced angiogenesis through
inhibiting tyrosine phosphorylation of VEGFR2. Life Sci.
82:956–963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zachary I and Gliki G: Signaling
transduction mechanisms mediating biological actions of the
vascular endothelial growth factor family. Cardiovasc Res.
49:568–581. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kowanetz M and Ferrara N: Vascular
endothelial growth factor signaling pathways: therapeutic
perspective. Clin Cancer Res. 12:5018–5022. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Madhusudan S and Ganesan TS: Tyrosine
kinase inhibitors in cancer therapy. Clin Biochem. 37:618–635.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tabernero J, Yoshino T, Cohn AL,
Obermannova R, Bodoky G, GarciaCarbonero R, Ciuleanu TE, Portnoy
DC, Van Cutsem E, Grothey A, et al: Ramucirumab versus placebo in
combination with second-line FOLFIRI in patients with metastatic
colorectal carcinoma that progressed during or after first-line
therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine
(RAISE): a randomised, double-blind, multicentre, phase 3 study.
Lancet Oncol. 16:499–508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh R, Kim WJ, Kim PH and Hong HJ:
Combined blockade of HER2 and VEGF exerts greater growth inhibition
of HER2-overexpressing gastric cancer xenografts than individual
blockade. Exp Mol Med. 45:e522013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sivonová M, Tatarková Z, Duracková Z,
Dobrota D, Lehotský J, Matáková T and Kaplán P: Relationship
between antioxidant potential and oxidative damage to lipids,
proteins and DNA in aged rats. Physiol Res. 56:757–764.
2007.PubMed/NCBI
|
|
15
|
Peshavariya HM, Liu GS, Chang CW, Jiang F,
Chan EC and Dusting GJ: Prostacyclin signaling boosts NADPH oxidase
4 in the endothelium promoting cytoprotection and angiogenesis.
Antioxid Redox Signal. 20:2710–2725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Swartz HM: Interactions between cells and
nitroxides and their implications for their uses as biophysical
probes and as metabolically responsive contrast agents for in vivo
NMR. Bull Mag Res. 8:172–175. 1986.
|
|
17
|
Keana JFW, Lex L, Mann JS, et al: Novel
nitroxides for spin-labelling, -trapping and magnetic resonance
imaging applications. Pure Appl Chem. 62:201–205. 1990. View Article : Google Scholar
|
|
18
|
Gariboldi MB, Ravizza R, Petterino C,
Castagnaro M, Finocchiaro G and Monti E: Study of in vitro and in
vivo effects of the piperidinenitroxide Tempol - a potential new
therapeutic agent for gliomas. Eur J Cancer. 39:829–837. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang C, Yang F, Zhang XW, Wang SC, Li MH,
Lin LP and Ding J: Grateloupia longifolia polysaccharide inhibits
angiogenesis by down regulating tissue factor expression in HMEC-1
endothelial cells. Br J Pharmacol. 148:741–751. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vichai V and Kirtikara K: Sulforhodamine B
colorimetric assay for cytotoxicity screening. Nat Protoc.
1:1112–1116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kwak HJ, Park MJ, Park CM, Moon SI, Yoo
DH, Lee HC, Lee SH, Kim MS, Lee HW, Shin WS, et al: Emodin inhibits
vascular endothelial growth factor-A-induced angiogenesis by
blocking receptor-2 (KDR/Flk-1) phosphorylation. Int J Cancer.
118:2711–2720. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pang X, Yi Z, Zhang X, Moon SI, Yoo DH,
Lee HC, Lee SH, Kim MS, Lee HW and Shin WS:
Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth
by suppressing vascular endothelial growth factor receptor
2-mediated angiogenesis. Cancer Res. 69:5893–5900. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhuang J, Jiang T, Lu D, Luo Y, Zheng C,
Feng J, Yang D, Chen C and Yan X: NADPH oxidase 4 mediates reactive
oxygen species induction of CD146 dimerization in VEGF signal
transduction. Free Radic Biol Med. 49:227–236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim CW, Son KN, Choi SY and Kim J: Human
lactoferrinupregulates expression of KDR/Flk-1 and stimulates
VEGF-A-mediated endothelial cell proliferation and migration. FEBS
Lett. 580:4332–4336. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Augustin HG, Koh GY, Thurston G and
Alitalo K: Control of vascular morphogenesis and homeostasis
through the angiopoietin-Tie system. Nat Rev Mol Cell Biol.
10:165–177. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grant DS and Kleinman HK: Regulation of
capillary formation by laminin and other components of the
extracellular matrix. EXS. 79:317–333. 1977.
|
|
27
|
Takaha N, Resar LM, Vindivich D and Coffey
DS: High mobility group protein HMGI(Y) enhances tumor cell growth,
invasion, and matrix metalloproteinase-2 expression in prostate
cancer cells. Prostate. 60:160–167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Overall CM and López-Otín C: Strategies
for MMP inhibition in cancer: innovations for the post-trial era.
Nat Rev Cancer. 2:657–672. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mehta PB, Jenkins BL, McCarthy L, Thilak
L, Robson CN, Neal DE and Leung HY: MEK5 overexpression is
associated with metastatic prostate cancer and stimulates
proliferation, MMP-9 expression, and invasion. Oncogene.
22:1381–1389. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Veikkola T and Alitalo K: VEGFs, receptors
and angiogenesis. Semin Cancer Biol. 9:211–220. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim SL, Lee ST, Trang KT, Kim SH, Kim IH,
Lee SO, Kim DG and Kim SW: Parthenolide exerts inhibitory effects
on angiogenesis through the downregulation of VEGF/VEGFRs in
colorectal cancer. Int J Mol Med. 33:1261–1267. 2014.PubMed/NCBI
|
|
33
|
Huang S, Yang N, Liu Y, Hu L, Zhao J, Gao
J, Li Y, Li C, Zhang X and Huang T: Grape seed proanthocyanidins
inhibit angiogenesis via the downregulation of both vascular
endothelial growth factor andangiopoietin signaling. Nutr Res.
32:530–536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pyriochou A, Tsigkos S, Vassilakopoulos T,
Cottin T, Zhou Z, Gourzoulidou E, Roussos C, Waldmann H, Giannis A
and Papapetropoulos A: Anti-angiogenic properties of a sulindac
analogue. Br J Pharmacol. 152:1207–1214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Paeng SH, Jung WK, Park WS, Lee DS, Kim
GY, Choi YH, Seo SK, Jang WH, Choi JS, Lee YM, et al: Caffeic acid
phenethyl ester reduces the secretion of vascular endothelial
growth factor through the inhibition of the ROS, PI3K and HIF-1α
signaling pathways in human retinal pigment epithelial cells under
hypoxic conditions. Int J Mol Med. 35:1419–1426. 2015.PubMed/NCBI
|
|
36
|
Chen JX, Zeng H, Lawrence ML, Blackwell TS
and Meyrick B: Angiopoietin-1-induced angiogenesis is modulated by
endothelial NADPH oxidase. Am J Physiol Heart Circ Physiol.
291:H1563–H1572. 2006. View Article : Google Scholar : PubMed/NCBI
|
